Unity Biotechnology, Inc.
UBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,990 | -$39,860 | -$59,927 | -$60,725 |
| Dep. & Amort. | $867 | $1,182 | $2,180 | $2,880 |
| Deferred Tax | $0 | $0 | $0 | $920 |
| Stock-Based Comp. | $3,970 | $7,419 | $9,379 | $11,553 |
| Change in WC | $3,391 | -$4,391 | -$1,022 | -$631 |
| Other Non-Cash | -$3,103 | -$1,438 | -$1,639 | $943 |
| Operating Cash Flow | -$20,865 | -$38,651 | -$51,029 | -$45,060 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$11 | -$96 | -$195 |
| Net Acquisitions | $0 | $0 | $378 | -$39,508 |
| Inv. Purchases | $0 | -$28,609 | -$98,827 | -$81,492 |
| Inv. Sales/Matur. | $0 | $89,000 | $74,000 | $121,000 |
| Other Inv. Act. | $8,565 | $115 | $0 | $39,508 |
| Investing Cash Flow | $8,565 | $60,495 | -$24,545 | $39,313 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$20,000 | $0 | -$68 |
| Stock Issued | $77 | $5,107 | $58,065 | $18,572 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1,447 | $0 | $2,341 |
| Financing Cash Flow | $77 | -$16,340 | $56,240 | $20,845 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$12,223 | $7,067 | -$20,719 | $15,098 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,699 | $13,632 | $34,351 | $19,253 |
| End Cash | $8,476 | $20,699 | $13,632 | $34,351 |
| Free Cash Flow | -$20,865 | -$37,099 | -$51,125 | -$45,255 |